MarketPeel
Insider Trading Intelligence
Pricing
…
JL

James Paul Lang

BIVI
DIRECTOR · BIOVIE INC. · CIK 0001703090
FILING MIX · LIFETIME87%/13%
BUYS
34
SELLS
5
TOTAL VALUE
$3.92M
COMPANIES
3
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
528,522
AVG SELL PX
—
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by James Paul Lang, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%+4.29%-1.74%+6.03%+6.03%—
14d2+50.00%+2.07%-4.03%+6.10%+6.10%—
30d2+50.00%-0.02%-5.75%+5.73%+5.73%—
60d2+50.00%+18.40%-3.57%+21.97%+21.97%—
90d2+100.00%+63.54%+0.69%+62.86%+62.86%—
180d2+100.00%+69.57%+7.58%+61.99%+61.99%—
1y2+0.00%-31.99%+11.56%-43.55%-43.55%—
2y2(1 pending)+0.00%-47.65%+36.62%-84.26%-84.26%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BIVI · 90,000 shares · as of Jan 5, 2026
082,625165,250247,875330,500202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 34 buys / 5 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
34,517——433,837Jun 9, 2026Jun 10, 2026 ↗View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,040——6,040May 5, 2026May 7, 2026 ↗View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,796——4,685May 5, 2026May 7, 2026 ↗View →
BIVI
BIOVIE INC.
PURCHASEGRANT
Stock grant
330,500——330,500Jan 5, 2026Jan 9, 2026 ↗View →
BIVI
BIOVIE INC.
PURCHASEGRANT
Stock grant
90,000——90,000Jan 5, 2026Jan 9, 2026 ↗View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
889——889Jan 2, 2026Jan 6, 2026 ↗View →
HALO
HALOZYME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,342——1,342Jan 2, 2026Jan 6, 2026 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
9,868——399,320Jun 11, 2025Jun 12, 2025 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASE
321,408$7.60$2.44M389,452Mar 14, 2025Mar 19, 2025 ↗View →
BIVI
BIOVIE INC.
PURCHASEGRANT
Stock grant
22,690——22,690Dec 20, 2024Jan 7, 2025 ↗View →
BIVI
BIOVIE INC.
PURCHASEGRANT
Stock grant
61,600——61,600Nov 20, 2024Jan 7, 2025 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
13,286——68,044Jun 7, 2024Jun 11, 2024 ↗View →
OPRX
OPTIMIZERX CORP
SALE
10,061——0Jun 5, 2024Jun 11, 2024 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASE
10,061——54,758Jun 5, 2024Jun 11, 2024 ↗View →
BIVI
BIOVIE INC.
PURCHASEGRANT
Stock grant
93,500——93,500Nov 9, 2023Dec 5, 2023 ↗View →
OPRX
OPTIMIZERX CORP
SALE
4,637——0Jun 7, 2023Aug 17, 2023 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
10,061——10,061Jun 7, 2023Aug 17, 2023 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASE
4,637——44,697Jun 7, 2023Aug 17, 2023 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASE
657——40,060Mar 30, 2023Apr 3, 2023 ↗View →
OPRX
OPTIMIZERX CORP
SALE
657——657Mar 30, 2023Apr 3, 2023 ↗View →
OPRX
OPTIMIZERX CORP
SALE
409——0Dec 30, 2022Jan 4, 2023 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASE
409——39,403Dec 30, 2022Jan 4, 2023 ↗View →
BIVI
BIOVIE INC.
PURCHASEGRANT
Stock grant
43,578——68,622Nov 23, 2022Jan 12, 2023 ↗View →
OPRX
OPTIMIZERX CORP
SALE
334——0Sep 29, 2022Sep 30, 2022 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASE
334——38,994Sep 29, 2022Sep 30, 2022 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASE
6,000$16.45$98.7K38,660Aug 19, 2022Aug 23, 2022 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
4,637——4,637Jun 9, 2022Jun 9, 2022 ↗View →
BIVI
BIOVIE INC.
PURCHASEGRANT
Stock grant
127,900——127,900Apr 5, 2022Apr 21, 2022 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
657——657Mar 30, 2022Apr 1, 2022 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
409——743Dec 30, 2021Jan 3, 2022 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
334——334Sep 29, 2021Oct 1, 2021 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
407——32,660Jun 30, 2021Jun 30, 2021 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
539——32,253Mar 31, 2021Apr 2, 2021 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
802——31,714Dec 31, 2020Jan 20, 2021 ↗View →
BIVI
BIOVIE INC.
PURCHASEGRANT
Stock grant
99,000$13.91$1.38M120,988Dec 18, 2020Mar 4, 2021 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
1,183——30,912Sep 30, 2020Jan 20, 2021 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
1,937——29,729Jun 30, 2020Jul 2, 2020 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
2,784——27,792Mar 30, 2020Mar 31, 2020 ↗View →
OPRX
OPTIMIZERX CORP
PURCHASEGRANT
Stock grant
2,084——25,008Jan 3, 2020Jan 7, 2020 ↗View →
Other insiders · BIVI
Loading peer insiders…
About this filer
CIK 0001703090
ROLE
Director
PRIMARY
BIVI
COMPANIES
3
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001703090DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback